[Clinical effect of prostenon in patients with resistant arterial hypertension and target organs complications].
Zeĭnalov
F M
FM
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002545:Brain Ischemia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D015232:Dinoprostone / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D018917:Optic Neuropathy, Ischemic / Q000188:drug therapy / Q000209:etiology*; D010120:Oxytocics / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D010120:Oxytocics; D015232:Dinoprostone